Hutch News

Hutch News

Stories tagged 'immunocompromised patients'

Tobias Hohl: Helping the immune system fight fungus

New VIDI investigator tracks down the cells and molecules used by human immune system to battle invasive fungal infections to improve care for immunocompromised patients

Aug. 24, 2009

Dr. Tobias Hohl came to the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Institute in May with a mission: to track down the cells and molecules used by human immune system to battle invasive fungal infections, in an effort to improve care for immunocompromised patients who contract fungal diseases. Hohl's win of a Young Investigator Award from the American Society for Microbiology in July underscores his progress in a challenging field—challenging because, compared to bacterial and viral pathogens, fungal diseases are understudied and difficult to diagnose and treat.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.